BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7647726)

  • 1. [Course of hay fever during the pollen season with respect to the effect of specific immunotherapy. II. Cytologic changes and chemotactic activity in nasal lavage].
    Rozniecka M; Kowałski ML; Grzegorczyk J; Wojciechowska B; Sliwińska-Kowalska M; Rozniecki J
    Pneumonol Alergol Pol; 1995; 63(3-4):144-52. PubMed ID: 7647726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of hay fever during pollen season with regard to the influence of specific immunotherapy. I. Clinical course and biochemical changes in nasal lavage].
    Rozniecka M; Kowalski M; Grzegorczyk J; Wojciechowska B; Sliwińska-Kowalska M; Rozniecki J
    Pneumonol Alergol Pol; 1995; 63(3-4):135-43. PubMed ID: 7647725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous histamine release by basophils and bronchial hyperreactivity in patients with hay fever].
    Medrala W; Małolepszy J; Wolańczyk-Medrala A; Wrzyszcz M; Rybakiewicz R; Litwa M
    Pneumonol Alergol Pol; 1995; 63(3-4):153-6. PubMed ID: 7544184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of immunotherapy on selected immunologic indices in children with pollinosis].
    Boznański A; Pirogowicz I; Widerska A; Hebrowska A
    Pediatr Pol; 1996 Jan; 71(1):15-8. PubMed ID: 8966061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circulating immune complexes in patients treated with Pollinex vaccine].
    Wrzyszcz M; Małolepszy J; Krasnowska M; Liebhart E; Medrala W; Kopeć W
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):737-9. PubMed ID: 2128120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific immunotherapy in the treatment of hay fever].
    Obtułowicz K
    Pol Tyg Lek; 1988 Jan 18-25; 43(3-4):97-101. PubMed ID: 3133645
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunotherapy in hayfever patients on histamine binding capacity of blood serum proteins.
    Zak-Nejmark T; Małolepszy J; Nadobna G; Ossos M; Liebhart J
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):693-7. PubMed ID: 3138963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with glutaraldehyde treated tyrosine adsorbed grass pollen in the treatment of allergic rhinitis.
    Small P; Shapiro M
    Ann Allergy; 1981 Dec; 47(6):443-5. PubMed ID: 6798900
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG and IgE antibody response following Pollinex-R immunotherapy.
    Ko HS; Chen SJ; Jaworska E
    Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis.
    Johansson S; Keen C; Ståhl A; Wennergren G; Benson M
    Allergy; 2005 May; 60(5):638-42. PubMed ID: 15813809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy.
    Ventura MT; Carretta A; Tummolo RA; Buquicchio R; Arsieni A; Murgia N
    Int J Immunopathol Pharmacol; 2009; 22(2):403-13. PubMed ID: 19505393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.
    Wilson DR; Irani AM; Walker SM; Jacobson MR; Mackay IS; Schwartz LB; Durham SR
    Clin Exp Allergy; 2001 Nov; 31(11):1705-13. PubMed ID: 11696046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].
    Kruszewski J
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():31-9. PubMed ID: 1843806
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioimmunologic tests in specific immunotherapy of atopic rhinitis].
    Ligeziński A
    Wiad Lek; 1984 Dec; 37(23):1846-50. PubMed ID: 6442498
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.